Side-by-side financials for BJDX and DXCM. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BJDX | DXCM |
|---|---|---|
| Market cap | - | $28.85 B |
| US-listed rank | - | #473 |
| Revenue (latest FY) | $249.04K | $4.66B |
| Net income (latest FY) | -$6.85M | $836.30M |
| Net margin | -2750.0% | 17.9% |
| P/E (trailing FY) | - | 34.5 |
| SEC filings | 219 | 2,566 |
In their latest fiscal years, Bluejay Diagnostics, Inc. reported $249.04K in revenue while DEXCOM INC reported $4.66B.
Full pages: Bluejay Diagnostics, Inc. and DEXCOM INC, or browse the full rankings.